Login

James P. Scriven, CEO of IDB Invest, focuses on Latin American finance and development in collaboration with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Northland Power CEO Mike Crawley Discusses Company's Growth, Resilience, and Investment Appeal | Mike Crawley, CEO, Northland Power Inc .
00:10:00
Journey of a Trailblazer: Gene's Path from Administrative Assistant to CEO of Wellington | Jean Hynes , CEO , Wellington Management.
00:10:00
At The Top: Accor CEO Sébastien Bazin | Sébastien Bazin, CEO , Accor SA.
00:10:00
lifelong learner and developer of talent|James Currier,General Partner,NFX
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Connecting Canadian and Aboriginal Businesses for Economic Success
00:00:00
Akers Biosciences Inc to be cash generative in second half - Raymond Akers, Executive chairman of Akers Biosciences Inc
00:10:00
Anastasia Amoroso, iCapital's Chief Investment Strategist, joins 'Closing Bell' to discuss the markets, the tech sector, and its broader economic impact.
00:10:00
Newfoundland and Labrador's Mining Industry: Resilience and Growth Amid Global Challenges
00:10:00
Benitec Biopharma Inc is a clinicalstage biotechnology company advancement of novel genetic medicines|Dr. Jerel Banks,Director,Benitec Biopharma Ltd
00:10:00
Building a Vision: Turning Dreams into a Global Movement| Nir Bar Dea, CO-CEO , Bridgewater Associates LP.
00:10:00
Dr. Martin Enderle, CEO of Scout24 Group.

© 2026 Nehu